Valuation Orion Oyj Nasdaq Helsinki

Stocks

Market Closed - Nasdaq Helsinki 17:00:00 23/10/2026 BST			5-day change	1st Jan Change
91.80 ^EUR	+0.33%		+5.52%	+45.02%

09:35am	Orion Corporation Announces Darolutamide Plus ADT And Radiation Therapy Reduces Risk Of Metastasis Or Death By 58% In Prostate Cancer Patients At High Risk Of Recurrence	CI
10-23	Inderes cuts Orion to Reduce (Add), target price €87	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,119	7,179	5,509	6,005	8,944	12,940	-	-
Change	-	40.25%	-23.26%	8.99%	48.95%	44.68%	-	-
Enterprise Value (EV) ¹	5,010	7,060	5,603	6,126	9,088	12,846	12,595	12,319
Change	-	40.91%	-20.65%	9.35%	48.35%	41.34%	-1.95%	-2.19%
P/E	26.5x	20.6x	25.5x	18.2x	17.9x	22.8x	19.4x	17.2x
PBR	6.86x	7.91x	6.19x	5.98x	6.97x	8.09x	6.53x	5.32x
PEG	-	0.3x	-0.7x	0.3x	0.3x	1.6x	1.1x	1.3x
Capitalization / Revenue	4.92x	5.36x	4.63x	3.89x	4.73x	6.15x	5.44x	5x
EV / Revenue	4.81x	5.27x	4.71x	3.97x	4.81x	6.1x	5.3x	4.76x
EV / EBITDA	17.3x	14.5x	17.2x	12x	13.2x	16.5x	13.9x	12.1x
EV / EBIT	20.6x	16.1x	20.4x	14.7x	14.4x	18x	15x	13x
EV / FCF	38.5x	21.7x	105x	29.7x	41.5x	25.8x	23.9x	19.5x
FCF Yield	2.6%	4.6%	0.95%	3.37%	2.41%	3.88%	4.18%	5.12%
Dividend per Share ²	1.5	1.6	1.62	1.64	1.8	1.965	2.17	2.508
Rate of return	4.11%	3.12%	4.13%	3.83%	2.83%	2.13%	2.35%	2.72%
EPS ²	1.38	2.49	1.54	2.35	3.56	4.056	4.749	5.374
Distribution rate	109%	64.3%	105%	69.8%	50.6%	48.4%	45.7%	46.7%
Net sales ¹	1,041	1,341	1,190	1,542	1,890	2,105	2,378	2,590
EBITDA ¹	289.1	487.1	326.4	509.4	688.3	778.2	906.9	1,014
EBIT ¹	243.3	439.6	274.9	416.6	631.6	715.3	837.6	945.3
Net income ¹	193.8	349.5	216.8	329.9	500.3	570.7	668.6	756.5
Net Debt ¹	-108.3	-118.7	93.3	121.7	144.4	-94.56	-345.3	-621.2
Reference price ²	36.52	51.24	39.27	42.78	63.65	92.30	92.30	92.30
Nbr of stocks (in thousands)	140,563	140,202	140,351	140,501	140,693	140,366	-	-
Announcement Date	10/02/22	09/02/23	13/02/24	25/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	636B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.46x	7.04x	18.70x	2.12%	444.93B
Weighted average by Cap.	35.14x	8.29x	20.39x	1.8%